Literature DB >> 21443683

The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer's disease.

Wei Qin1, Longfei Jia, Aihong Zhou, Xiumei Zuo, Zhe Cheng, Fen Wang, Fudong Shi, Jianping Jia.   

Abstract

We previously described an association between Alzheimer's disease (AD) and a single-nucleotide polymorphism -980C/G (rs3754048) in the promoter of the anterior pharynx-defective-1a (APH-1A) gene. Here, we examine the potential of this -980C/G polymorphism to affect APH-1A transcription and confer a risk of AD. We validated the presence of APH-1A promoter polymorphism -980C/G in other two Chinese cohort sets (450 AD and 450 controls). Subsequently, we measured APH-1A mRNA and protein levels and γ-secretase activity in C or G allele carriers. Finally, we examined the polymorphism's transcriptional function using a dual-luciferase reporter assay and also tracked transcription factor binding to the variant promoter sequence with electrophoretic mobility shift assays (EMSAs). We found that the APH-1A levels and γ-secretase activity were higher in individuals carrying allele G. The G allele increased APH-1A transcriptional activity significantly in both N2A cells and HEK293 cells. The EMSA revealed an increased binding of the transcription factor Yin Yang 1 (YY1) to allele G. Overexpression of YY1 resulted in an activation of the APH-1A promoter (2.7-fold). Specific YY1 siRNA led to decreases in APH-1A promoter activity and mRNA and protein levels. Our data indicate that the APH-1A promoter polymorphism -980C/G might alter the binding ability of YY1 transcription factor, resulting in an increased level of APH-1A and γ-secretase activity. These factors further facilitated β-amyloid (Aβ) 42 generation and ultimately modified patients' susceptibility to AD. The involvement of transcription factor YY1 might be a novel mechanism for the development of AD.
© 2011 The Authors. Aging Cell © 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21443683     DOI: 10.1111/j.1474-9726.2011.00708.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  4 in total

1.  Phosphorylated Tau 181 Serum Levels Predict Alzheimer's Disease in the Preclinical Stage.

Authors:  Wei Qin; Fangyu Li; Longfei Jia; Qi Wang; Ying Li; Yiping Wei; Yan Li; Hongmei Jin; Jianping Jia
Journal:  Front Aging Neurosci       Date:  2022-06-13       Impact factor: 5.702

2.  A Rare Variation in the 3' Untranslated Region of the Presenilin 2 Gene Is Linked to Alzheimer's Disease.

Authors:  Yana Pang; Tingting Li; Qi Wang; Wei Qin; Ying Li; Yiping Wei; Longfei Jia
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

3.  Reasoning over genetic variance information in cause-and-effect models of neurodegenerative diseases.

Authors:  Mufassra Naz; Alpha Tom Kodamullil; Martin Hofmann-Apitius
Journal:  Brief Bioinform       Date:  2015-08-05       Impact factor: 11.622

4.  Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.

Authors:  D M Vargas; M A De Bastiani; E R Zimmer; F Klamt
Journal:  Alzheimers Res Ther       Date:  2018-06-23       Impact factor: 6.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.